These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9800116)

  • 1. Screening for gynecologic cancers.
    Rosenthal AN
    Curr Opin Oncol; 1998 Sep; 10(5):447-51. PubMed ID: 9800116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary gynecologic cancers.
    Mutch D; Denny L; Quinn M;
    Int J Gynaecol Obstet; 2014 Mar; 124(3):189-92. PubMed ID: 24429354
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic and therapeutic advances in gynecologic oncology: screening for gynecologic cancer.
    Kim YB; Ghosh K; Ainbinder S; Berek JS
    Cancer Treat Res; 1998; 95():253-76. PubMed ID: 9619288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for gynecologic cancer.
    Zanotti KM; Kennedy AW
    Med Clin North Am; 1999 Nov; 83(6):1467-87. PubMed ID: 10584603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and prevention of hereditary gynecologic cancers.
    Kehoe SM; Kauff ND
    Semin Oncol; 2007 Oct; 34(5):406-10. PubMed ID: 17920895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gynecologic cancers].
    Sekiba K; Akamatsu N
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1699-714. PubMed ID: 6332575
    [No Abstract]   [Full Text] [Related]  

  • 7. Screening in gynecologic cancers.
    Averette HE; Steren A; Nguyen HN
    Cancer; 1993 Aug; 72(3 Suppl):1043-9. PubMed ID: 8392908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and early diagnosis of gynecologic cancers.
    Warner EA; Parsons AK
    Med Clin North Am; 1996 Jan; 80(1):45-61. PubMed ID: 8569300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimum screening interventions for gynecologic malignancies.
    Lea JS; Miller DS
    Tex Med; 2001 Feb; 97(2):49-55. PubMed ID: 11233059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility and economic impact of a clinical pathway for pap test utilization in Gynecologic Oncology practice.
    Santillan A; Govan L; Zahurak ML; Diaz-Montes TP; Giuntoli RL; Bristow RE
    Gynecol Oncol; 2008 Jun; 109(3):388-93. PubMed ID: 18405946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Screening and Prevention Highlights in Gynecologic Cancer.
    Staples JN; Duska LR
    Obstet Gynecol Clin North Am; 2019 Mar; 46(1):19-36. PubMed ID: 30683264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Office screening for gynecologic cancer.
    Zweizig SL
    Clin Obstet Gynecol; 1999 Jun; 42(2):267-75. PubMed ID: 10370846
    [No Abstract]   [Full Text] [Related]  

  • 13. MicroRNA and gynecologic cancers.
    Kanekura K; Nishi H; Isaka K; Kuroda M
    J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predisposition in gynecologic cancers.
    Daniels MS; Lu KH
    Semin Oncol; 2016 Oct; 43(5):543-547. PubMed ID: 27899185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial ovarian screening--effective or ineffective?
    Jacobs IJ; Mackay J; Menon U; Skates SJ; Rosenthal AN; Fraser L
    Br J Cancer; 2006 Oct; 95(8):1124; author reply 1126-7. PubMed ID: 17047658
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.
    Singh J; Thota N; Singh S; Padhi S; Mohan P; Deshwal S; Sur S; Ghosh M; Agarwal A; Sarin R; Ahmed R; Almel S; Chakraborti B; Raina V; DadiReddy PK; Smruti BK; Rajappa S; Dodagoudar C; Aggarwal S; Singhal M; Joshi A; Kumar R; Kumar A; Mishra DK; Arora N; Karaba A; Sankaran S; Katragadda S; Ghosh A; Veeramachaneni V; Hariharan R; Mannan AU
    Breast Cancer Res Treat; 2018 Jul; 170(1):189-196. PubMed ID: 29470806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for screening, diagnosis, and monitoring of ovarian cancer.
    Kobayashi E; Ueda Y; Matsuzaki S; Yokoyama T; Kimura T; Yoshino K; Fujita M; Kimura T; Enomoto T
    Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):1902-12. PubMed ID: 22962405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?
    Mitchell G; Schrader KA
    Surg Pathol Clin; 2016 Jun; 9(2):301-6. PubMed ID: 27241110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating tumor markers in gynecological tumors.
    Rustin GJ
    Curr Opin Oncol; 1996 Sep; 8(5):426-31. PubMed ID: 8914810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for gynecologic malignancies: A continuing responsibility.
    Runowicz CD; Fields AL
    Surg Oncol Clin N Am; 1999 Oct; 8(4):703-23, vii. PubMed ID: 10452936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.